BR9507289A - Derivados de éster e carbamato de azolonas com atividade anti-heli-cobacteriana - Google Patents
Derivados de éster e carbamato de azolonas com atividade anti-heli-cobacterianaInfo
- Publication number
- BR9507289A BR9507289A BR9507289A BR9507289A BR9507289A BR 9507289 A BR9507289 A BR 9507289A BR 9507289 A BR9507289 A BR 9507289A BR 9507289 A BR9507289 A BR 9507289A BR 9507289 A BR9507289 A BR 9507289A
- Authority
- BR
- Brazil
- Prior art keywords
- image
- pct
- 4alkyl
- 6alkyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Detergent Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94200938 | 1994-04-06 | ||
| PCT/EP1995/001184 WO1995027704A1 (en) | 1994-04-06 | 1995-03-29 | Anti-helicobacter ester and carbamate derivatives of azolones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9507289A true BR9507289A (pt) | 1997-09-23 |
Family
ID=8216773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9507289A BR9507289A (pt) | 1994-04-06 | 1995-03-29 | Derivados de éster e carbamato de azolonas com atividade anti-heli-cobacteriana |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5710156A (pt) |
| EP (1) | EP0754180B1 (pt) |
| JP (1) | JPH09511513A (pt) |
| CN (1) | CN1145067A (pt) |
| AT (1) | ATE207910T1 (pt) |
| AU (1) | AU685935B2 (pt) |
| BR (1) | BR9507289A (pt) |
| CA (1) | CA2185552A1 (pt) |
| CZ (1) | CZ287596A3 (pt) |
| DE (1) | DE69523581T2 (pt) |
| EE (1) | EE9600142A (pt) |
| FI (1) | FI963995A (pt) |
| HU (1) | HUT76287A (pt) |
| IL (1) | IL113254A (pt) |
| NO (1) | NO964216L (pt) |
| NZ (1) | NZ283346A (pt) |
| PL (1) | PL316655A1 (pt) |
| SK (1) | SK127196A3 (pt) |
| WO (1) | WO1995027704A1 (pt) |
| ZA (1) | ZA952810B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| US5250528A (en) * | 1989-08-02 | 1993-10-05 | Fujisawa Pharmaceutical Co., Ltd. | New aminopiperazine derivatives |
| CA2076257A1 (en) * | 1991-09-13 | 1993-03-14 | Jan Heeres | 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives |
| US5202346A (en) * | 1992-02-25 | 1993-04-13 | American Home Products Corporation | Piperidinyl and piperazinyl derivatives |
| TW279864B (pt) * | 1993-02-19 | 1996-07-01 | Janssen Pharmaceutica Nv |
-
1995
- 1995-03-29 AU AU21371/95A patent/AU685935B2/en not_active Ceased
- 1995-03-29 SK SK1271-96A patent/SK127196A3/sk unknown
- 1995-03-29 CN CN95192436A patent/CN1145067A/zh active Pending
- 1995-03-29 WO PCT/EP1995/001184 patent/WO1995027704A1/en active IP Right Grant
- 1995-03-29 BR BR9507289A patent/BR9507289A/pt not_active Application Discontinuation
- 1995-03-29 DE DE69523581T patent/DE69523581T2/de not_active Expired - Fee Related
- 1995-03-29 EP EP95914329A patent/EP0754180B1/en not_active Expired - Lifetime
- 1995-03-29 NZ NZ283346A patent/NZ283346A/en unknown
- 1995-03-29 AT AT95914329T patent/ATE207910T1/de not_active IP Right Cessation
- 1995-03-29 CZ CZ962875A patent/CZ287596A3/cs unknown
- 1995-03-29 HU HU9602725A patent/HUT76287A/hu unknown
- 1995-03-29 CA CA002185552A patent/CA2185552A1/en not_active Abandoned
- 1995-03-29 US US08/716,397 patent/US5710156A/en not_active Expired - Fee Related
- 1995-03-29 JP JP7526047A patent/JPH09511513A/ja not_active Ceased
- 1995-03-29 PL PL95316655A patent/PL316655A1/xx unknown
- 1995-03-29 EE EE9600142A patent/EE9600142A/xx unknown
- 1995-04-05 IL IL11325495A patent/IL113254A/xx not_active IP Right Cessation
- 1995-04-05 ZA ZA952810A patent/ZA952810B/xx unknown
-
1996
- 1996-10-04 FI FI963995A patent/FI963995A/fi unknown
- 1996-10-04 NO NO964216A patent/NO964216L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0754180B1 (en) | 2001-10-31 |
| MX9604610A (es) | 1997-11-29 |
| SK127196A3 (en) | 1997-05-07 |
| EP0754180A1 (en) | 1997-01-22 |
| HUT76287A (en) | 1997-07-28 |
| AU2137195A (en) | 1995-10-30 |
| NZ283346A (en) | 1997-05-26 |
| NO964216D0 (no) | 1996-10-04 |
| NO964216L (no) | 1996-10-04 |
| WO1995027704A1 (en) | 1995-10-19 |
| CZ287596A3 (en) | 1997-01-15 |
| DE69523581T2 (de) | 2002-07-11 |
| CA2185552A1 (en) | 1995-10-19 |
| HU9602725D0 (en) | 1996-11-28 |
| CN1145067A (zh) | 1997-03-12 |
| FI963995A0 (fi) | 1996-10-04 |
| JPH09511513A (ja) | 1997-11-18 |
| ZA952810B (en) | 1996-10-07 |
| AU685935B2 (en) | 1998-01-29 |
| EE9600142A (et) | 1997-04-15 |
| IL113254A0 (en) | 1995-07-31 |
| FI963995A (fi) | 1996-10-04 |
| DE69523581D1 (de) | 2001-12-06 |
| ATE207910T1 (de) | 2001-11-15 |
| US5710156A (en) | 1998-01-20 |
| IL113254A (en) | 1999-03-12 |
| PL316655A1 (en) | 1997-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700340A (es) | Agentes anti-helicobacter derivados sulfonamida de azolonas. | |
| MX9700339A (es) | Derivados de azolona anti-helcobacter que contienen urea y tiourea. | |
| NZ237023A (en) | 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions | |
| BR9507289A (pt) | Derivados de éster e carbamato de azolonas com atividade anti-heli-cobacteriana | |
| DE69720715D1 (en) | Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel | |
| ES2094545T3 (es) | Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc.. | |
| MA18904A1 (fr) | "2-dihalogenomethylene-3-halogeno-3-alcoxycarbonyl-5 oxopyrrolidines,procede pour leur preparation et leur utilisation comme agentsphytosanitaires fongicides,bactericides et algicides | |
| ES2094567T3 (es) | Derivados de la 4-quinolinilo con actividad anti-helicobacter. | |
| MY120046A (en) | Angiogenesis inhibiting thiadiazolyl pyridazine derivatives. | |
| GR3025050T3 (en) | Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer. | |
| MY118312A (en) | Angiogenesis inhibiting 5- substituted- 1,2,4- thiadiazolyl derivatives | |
| NO20000114D0 (no) | 2,4,4-trisubstituerte-1,3-diokolan-antifungale midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
| FA8 | Dismissal: dismissal - article 36, par. 1 of industrial property law |